Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 65, Issue 6, Pages 1430-1438
Publisher
Wiley
Online
2013-03-05
DOI
10.1002/art.37916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation
- (2013) Bruce W Kirkham et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis
- (2012) Claire Immediato Daïen et al. ANNALS OF THE RHEUMATIC DISEASES
- Fasting Time and Lipid Levels in a Community-Based Population
- (2012) Davinder Sidhu et al. ARCHIVES OF INTERNAL MEDICINE
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
- (2012) Larry W. Moreland et al. ARTHRITIS AND RHEUMATISM
- Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
- (2011) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
- (2010) A. Jamnitski et al. ANNALS OF THE RHEUMATIC DISEASES
- Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
- (2010) D. H. Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
- (2010) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis
- (2010) Eduardo Nicolas Pollono et al. CLINICAL RHEUMATOLOGY
- Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
- (2010) C. P. CHUNG et al. JOURNAL OF RHEUMATOLOGY
- Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
- (2010) Anne G. Semb et al. RHEUMATOLOGY
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Total cholesterol and LDL levels decrease before rheumatoid arthritis
- (2009) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis
- (2009) Manfredi Rizzo et al. ATHEROSCLEROSIS
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis
- (2008) Frederick Wolfe et al. ARTHRITIS AND RHEUMATISM
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
- (2007) A Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now